LY75 and cancer: The broad expressionprofile of DEC205 in human cells complicates interspecies comparison.93 The first in-human targeted cancer vaccine consistedof an anti-DEC205 mAb fused to the cancer testis antigen NY-ESO-1adjuvanted with coadministered poly-I:C (CDX-1401).